BMRN
Price
$58.05
Change
-$0.42 (-0.72%)
Updated
May 22, 12:26 PM (EDT)
Capitalization
11.22B
75 days until earnings call
SRPT
Price
$38.95
Change
-$1.11 (-2.77%)
Updated
May 22, 12:56 PM (EDT)
Capitalization
3.94B
69 days until earnings call
Interact to see
Advertisement

BMRN vs SRPT

Header iconBMRN vs SRPT Comparison
Open Charts BMRN vs SRPTBanner chart's image
BioMarin Pharmaceutical
Price$58.05
Change-$0.42 (-0.72%)
Volume$400
Capitalization11.22B
Sarepta Therapeutics
Price$38.95
Change-$1.11 (-2.77%)
Volume$500
Capitalization3.94B
BMRN vs SRPT Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. SRPT commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and SRPT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (BMRN: $58.48 vs. SRPT: $40.05)
Brand notoriety: BMRN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 120% vs. SRPT: 202%
Market capitalization -- BMRN: $11.22B vs. SRPT: $3.94B
BMRN [@Biotechnology] is valued at $11.22B. SRPT’s [@Biotechnology] market capitalization is $3.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, BMRN is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 3 TA indicator(s) are bullish while SRPT’s TA Score has 6 bullish TA indicator(s).

  • BMRN’s TA Score: 3 bullish, 2 bearish.
  • SRPT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а -0.37% price change this week, while SRPT (@Biotechnology) price change was +12.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was -1.66%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

SRPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($11.2B) has a higher market cap than SRPT($3.94B). SRPT has higher P/E ratio than BMRN: SRPT (27.21) vs BMRN (21.66). BMRN YTD gains are higher at: -11.030 vs. SRPT (-67.061). BMRN has higher annual earnings (EBITDA): 777M vs. SRPT (-106.51M). BMRN has more cash in the bank: 1.27B vs. SRPT (523M). BMRN has less debt than SRPT: BMRN (602M) vs SRPT (1.34B). BMRN has higher revenues than SRPT: BMRN (2.95B) vs SRPT (2.23B).
BMRNSRPTBMRN / SRPT
Capitalization11.2B3.94B285%
EBITDA777M-106.51M-730%
Gain YTD-11.030-67.06116%
P/E Ratio21.6627.2180%
Revenue2.95B2.23B132%
Total Cash1.27B523M243%
Total Debt602M1.34B45%
FUNDAMENTALS RATINGS
BMRN vs SRPT: Fundamental Ratings
BMRN
SRPT
OUTLOOK RATING
1..100
732
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6096
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (64) in the Biotechnology industry is in the same range as SRPT (67). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

BMRN's SMR Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

BMRN's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for SRPT (96). This means that BMRN’s stock grew somewhat faster than SRPT’s over the last 12 months.

BMRN's P/E Growth Rating (98) in the Biotechnology industry is in the same range as SRPT (100). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNSRPT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 1 day ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
62%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
URNM36.880.10
+0.27%
Sprott Uranium Miners ETF
CNYCHF0.11N/A
N/A
China Yuan - Switzerland Franc
AUDHKD5.03N/A
N/A
Australian Dollar - Hong Kong Dollar
HIX4.13-0.04
-0.96%
Western Asset High Income Fund II
INDS35.86-1.09
-2.96%
Pacer Benchmark Industrial RE SCTR ETF

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-2.42%
ITOS - BMRN
51%
Loosely correlated
-1.56%
IBO - BMRN
46%
Loosely correlated
+3.64%
SRPT - BMRN
45%
Loosely correlated
+0.15%
IONS - BMRN
43%
Loosely correlated
-2.81%
AXON - BMRN
42%
Loosely correlated
-0.99%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with ALZN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+0.15%
ALZN - SRPT
49%
Loosely correlated
N/A
RCKT - SRPT
45%
Loosely correlated
-3.80%
INSM - SRPT
44%
Loosely correlated
-3.63%
AXON - SRPT
43%
Loosely correlated
-0.99%
TECX - SRPT
41%
Loosely correlated
-8.06%
More